Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.

Biotechnology

Stelexis Therapeutics

Stelexis Therapeutics' headquarters in New York, NY, United States

Jiahao Chen

Lynn Biderman

Lumie Benard

Bozena Bugaj-Gaweda

Zhuoxun Wu

Alice Tang

Jason Fuller

Uli Steidl

Evripids Gavathiotis

Roman Perez-Soler

Amit Verma

Mark Shtilerman

Derrick Rossi

Jonathan Ramos

The Research and Development team at Stelexis Therapeutics is focused on pioneering breakthrough cancer treatments. They leverage the Tumororigin™ platform and advanced drug discovery techniques to identify and develop novel therapeutic agents. This team plays a critical role in conducting cutting-edge research, managing lab operations, and translating scientific discoveries into viable cancer therapies aimed at improving patient outcomes.

Research and Development

Stelexis Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Offices

Stelexis Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Offices

Related companies